Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
CD4 T cells in chronic myeloid leukemia present MHC class II-dependent and IFN-γ-dependent cytotoxic capacity.
Med Oncol. 2023 Jul 27;40(9):253. doi: 10.1007/s12032-023-02123-5.
Med Oncol. 2023.
PMID: 37498412
Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells.
Jiang Y, Liu L, Jiang Y, Li Z, Feng L, Zhuang X, Lin Z, Chen Q, Chen G, He J, Li G, Zha J, Xu B.
Jiang Y, et al.
Pharmaceuticals (Basel). 2022 Oct 25;15(11):1313. doi: 10.3390/ph15111313.
Pharmaceuticals (Basel). 2022.
PMID: 36355485
Free PMC article.
Item in Clipboard
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.
Chen Q, Deng S, Deng M, Shi Y, Zhong M, Ding L, Jiang Y, Zhou Y, Carter BZ, Xu B.
Chen Q, et al.
Exp Hematol Oncol. 2022 Apr 16;11(1):23. doi: 10.1186/s40164-022-00276-z.
Exp Hematol Oncol. 2022.
PMID: 35429966
Free PMC article.
Item in Clipboard
The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L, Zhou Y, Chen K, Shi P, Li Y, Deng M, Jiang Z, Wang X, Li P, Xu B.
Zhang L, et al.
Target Oncol. 2017 Oct;12(5):677-687. doi: 10.1007/s11523-017-0509-2.
Target Oncol. 2017.
PMID: 28710745
Item in Clipboard
Cite
Cite